SCHEMBL2806738

SCHEMBL2806738

CCOC(=O)C1=Nc2ccccc2C1=[N+]=[N-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 1.00
LMNA P02545 3/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
HSP90AA1 P07900 1/20 1.00
HTT P42858 1/20 1.00
HIF1A Q16665 1/20 1.00
FGB P02675 1/20 0.51
KDM4E B2RXH2 3/20 0.47
KMT2A Q03164 3/20 0.47
TSHR P16473 1/20 0.42
ALDH1A1 P00352 5/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 2/20 0.39
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2350732 1.00 MAPT (1.00) MAPTLMNASMN1; SMN2HSP90AA1HTT
Acetic Acid SCHEMBL7467661 0.96 MAPT (0.92) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL5216260 0.81 MAPT (0.67) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL4738113 0.80 MAPT (0.66) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL6594697 0.79 MAPT (0.65) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL7083034 0.79 LMNA (0.65) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL14270581 0.78 MAPT (0.64) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL7460180 0.77 LMNA (0.62) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL7460200 0.77 LMNA (0.62) MAPTLMNASMN1; SMN2HSP90AA1HTT
SCHEMBL15111207 0.72 MAPT (0.56) MAPTLMNASMN1; SMN2HSP90AA1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
EP-2081894-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SmithKline Beecham Corporation (US) 2009-07-29 EP disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators PPARD, PPARA, PPARG MAPT 2916/4885LMNA 3033/4885SMN1; SMN2 4776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.